Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | PPARG | P37231 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | POLA1 | P09884 | 1/20 | 0.43 |
| ▸ | PPARA | Q07869 | 1/20 | 0.43 |
| ▸ | DGKA | P23743 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15823932 | 0.96 | CA12 (0.44) | CA12CA14CA2CA7CA9 | |
| SCHEMBL15823849 | 0.94 | CA12 (0.50) | CA12CA14CA2CA7CA9 | |
| SCHEMBL15824674 | 0.94 | CA12 (0.50) | CA12CA14CA2CA7CA9 | |
| SCHEMBL15833854 | 0.92 | CA12 (0.49) | CA12CA14CA2CA7CA9 | |
| SCHEMBL15833856 | 0.92 | CA12 (0.49) | CA12CA14CA2CA7CA9 | |
| SCHEMBL15833853 | 0.92 | CA12 (0.49) | CA12CA14CA2CA7CA9 | |
| SCHEMBL17255846 | 0.88 | FFAR4 (0.51) | CA12CA14CA2CA7CA9 | |
| SCHEMBL15823706 | 0.85 | CA12 (0.48) | CA12CA14CA2CA7CA9 | |
| SCHEMBL15824123 | 0.85 | CA12 (0.48) | CA12CA14CA2CA7CA9 | |
| SCHEMBL15822897 | 0.85 | CA12 (0.48) | CA12CA14CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150329484-A1 | ESTER HAVING SULPHONE GROUP | EVONIK DEGUSSA GMBH (DE) | 2015-11-19 | — | — | US | disclosed |
| US-20150329484-A1 | ESTER HAVING SULPHONE GROUP | EVONIK DEGUSSA GMBH (DE) | 2015-11-19 | — | — | US | disclosed |
| WO-2014095103-A1 | ESTER HAVING A SULPHONIC GROUP | EVONIK INDUSTRIES AG (DE) | 2014-06-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150329484-A1 | ESTER HAVING SULPHONE GROUP | STS, SULT1A1, TST | CA12 3918/4885CA14 2379/4885CA2 4790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.